Cadrenal Therapeutics, Inc.
CVKD
$1.19
-$0.01-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -33.09% | 17.85% | -13.15% | 26.77% | 4.63% |
| Total Depreciation and Amortization | -16.67% | 0.00% | 50.00% | 0.00% | -92.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 166.28% | -22.36% | -31.33% | -20.11% | 7.98% |
| Change in Net Operating Assets | 154.94% | -629.01% | 198.76% | -400.00% | 103.56% |
| Cash from Operations | 25.61% | -16.82% | -9.03% | 22.10% | 34.91% |
| Capital Expenditure | -- | -- | 100.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.30% | -55.86% | 352.65% | -48.34% | -35.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3,569.06% | 83.09% | -963.20% | 44.11% | 25.32% |
| Cash from Financing | 77.47% | -52.07% | 319.14% | -48.56% | -36.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.71% | -1,250.78% | 108.63% | 3.10% | 34.18% |